D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 42 Citations 7,494 121 World Ranking 14867 National Ranking 6210

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Internal medicine

Haematopoiesis, Stem cell factor, Bone marrow, Molecular biology and Cancer research are his primary areas of study. His Haematopoiesis study frequently draws connections between related disciplines such as Cellular differentiation. The concepts of his Stem cell factor study are interwoven with issues in Cell type and Immunology.

Feng Chun Yang has included themes like Progenitor cell, GTPase and Cdc42 GTP-Binding Protein in his Bone marrow study. His biological study spans a wide range of topics, including Guanosine, Endocrinology and Internal medicine, Lymphocyte. His study in Cancer research is interdisciplinary in nature, drawing from both Tumor suppressor gene, Neurofibromin 1 and Mast cell.

His most cited work include:

  • Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. (424 citations)
  • Nf1-Dependent Tumors Require a Microenvironment Containing Nf1+/−- and c-kit-Dependent Bone Marrow (275 citations)
  • Collection, Cryopreservation, and Characterization of Human Dental Pulp–Derived Mesenchymal Stem Cells for Banking and Clinical Use (207 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Cancer research, Haematopoiesis, Bone marrow, Immunology and Cell biology. His Cancer research research includes elements of Neurofibromin 1, Leukemia and Pathogenesis. His studies examine the connections between Haematopoiesis and genetics, as well as such issues in Progenitor cell, with regards to CD34.

His Bone marrow research is multidisciplinary, relying on both Molecular biology, Endocrinology, Mesenchymal stem cell and Transplantation. His research integrates issues of Myelopoiesis and FANCG in his study of Immunology. Feng Chun Yang mostly deals with Stem cell factor in his studies of Cell biology.

He most often published in these fields:

  • Cancer research (55.66%)
  • Haematopoiesis (44.81%)
  • Bone marrow (41.04%)

What were the highlights of his more recent work (between 2015-2021)?

  • Cancer research (55.66%)
  • Haematopoiesis (44.81%)
  • Myeloid (32.55%)

In recent papers he was focusing on the following fields of study:

Feng Chun Yang mainly investigates Cancer research, Haematopoiesis, Myeloid, Myeloid leukemia and Leukemia. Feng Chun Yang interconnects Pathogenesis, Mutation, Apoptosis, Stem cell and Bone marrow in the investigation of issues within Cancer research. His Haematopoiesis study integrates concerns from other disciplines, such as Progenitor cell, Epigenetics and Immunology.

His research in Immunology intersects with topics in Regulator and Myelopoiesis. Feng Chun Yang has included themes like Cancer, Transcription factor, Gene mutation, CD34 and CARM1 in his Myeloid study. His research in Myeloid leukemia intersects with topics in Histone, Drug resistance and Decitabine.

Between 2015 and 2021, his most popular works were:

  • Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies. (74 citations)
  • Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells (47 citations)
  • Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells (47 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

His primary scientific interests are in Haematopoiesis, Myeloid leukemia, Cancer research, Myeloid and Leukemia. His work on Haematopoiesis is being expanded to include thematically relevant topics such as Progenitor cell. His Myeloid leukemia research also works with subjects such as

  • Hematology that intertwine with fields like Ectopic expression, microRNA and Oncology,
  • Histone together with Transgene, DNA methylation and Molecular biology.

In his study, Cord blood is strongly linked to Bone marrow, which falls under the umbrella field of Myeloid. His biological study deals with issues like Stem cell, which deal with fields such as Regeneration and Cytokine. His Immunology research incorporates themes from Tyrosine kinase, Drug resistance and Kinase activity.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies.

Zhe Li;Xiaoqiang Cai;Chen Leng Cai;Jiapeng Wang.
Blood (2011)

588 Citations

Collection, Cryopreservation, and Characterization of Human Dental Pulp–Derived Mesenchymal Stem Cells for Banking and Clinical Use

Brandon C. Perry;Dan Zhou;Xiaohua Wu;Feng Chun Yang.
Tissue Engineering Part C-methods (2008)

346 Citations

Nf1-Dependent Tumors Require a Microenvironment Containing Nf1+/−- and c-kit-Dependent Bone Marrow

Feng Chun Yang;David A. Ingram;Shi Chen;Yuan Zhu.
Cell (2008)

341 Citations

Rac and Cdc42 GTPases control hematopoietic stem cell shape, adhesion, migration, and mobilization

Feng-Chun Yang;Simon J Atkinson;Ying Gu;Ying Gu;Jovencio B Borneo;Jovencio B Borneo.
Proceedings of the National Academy of Sciences of the United States of America (2001)

289 Citations

Rac2 stimulates Akt activation affecting BAD/Bcl-XL expression while mediating survival and actin function in primary mast cells.

Feng Chun Yang;Reuben Kapur;Alastair J. King;Wen Tao.
Immunity (2000)

244 Citations

Leptin stimulates the proliferation of murine myelocytic and primitive hematopoietic progenitor cells

Yumi Umemoto;Kohichiro Tsuji;Kohichiro Tsuji;Feng Chun Yang;Feng Chun Yang;Yasuhiro Ebihara;Yasuhiro Ebihara.
Blood (1997)

240 Citations

Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/– mast cells

Feng Chun Yang;David A. Ingram;Shi Chen;Cynthia M. Hingtgen.
Journal of Clinical Investigation (2003)

228 Citations

Genetic and Biochemical Evidence That Haploinsufficiency of the Nf1 Tumor Suppressor Gene Modulates Melanocyte and Mast Cell Fates in Vivo

David A. Ingram;Feng Chun Yang;Jeffrey B. Travers;Mary Jo Wenning.
Journal of Experimental Medicine (2000)

215 Citations

Stimulation of mouse and human primitive hematopoiesis by murine embryonic aorta-gonad-mesonephros-derived stromal cell lines.

Ming Jiang Xu;Kohichiro Tsuji;Kohichiro Tsuji;Takahiro Ueda;Takahiro Ueda;Yoh Suke Mukouyama;Yoh Suke Mukouyama.
Blood (1998)

196 Citations

Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial

Kent A. Robertson;Grzegorz Nalepa;Feng Chun Yang;Daniel C. Bowers.
Lancet Oncology (2012)

173 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Feng Chun Yang

David H. Gutmann

David H. Gutmann

Washington University in St. Louis

Publications: 66

Jose A. Cancelas

Jose A. Cancelas

Cincinnati Children's Hospital Medical Center

Publications: 48

David A. Williams

David A. Williams

Boston Children's Hospital

Publications: 44

Yi Zheng

Yi Zheng

Cincinnati Children's Hospital Medical Center

Publications: 43

Nancy Ratner

Nancy Ratner

Cincinnati Children's Hospital Medical Center

Publications: 39

Ross L. Levine

Ross L. Levine

Memorial Sloan Kettering Cancer Center

Publications: 37

Tatsutoshi Nakahata

Tatsutoshi Nakahata

Kyoto University

Publications: 35

David A. Ingram

David A. Ingram

Indiana University

Publications: 32

Anjana Rao

Anjana Rao

La Jolla Institute For Allergy & Immunology

Publications: 28

Kohichiro Tsuji

Kohichiro Tsuji

University of Tokyo

Publications: 27

Omar Abdel-Wahab

Omar Abdel-Wahab

Memorial Sloan Kettering Cancer Center

Publications: 27

Mingjiang Xu

Mingjiang Xu

National Institutes of Health

Publications: 22

Luis F. Parada

Luis F. Parada

Memorial Sloan Kettering Cancer Center

Publications: 21

Toshio Kitamura

Toshio Kitamura

University of Tokyo

Publications: 20

Jianjun Chen

Jianjun Chen

University of Cincinnati

Publications: 18

David H. Viskochil

David H. Viskochil

University of Utah

Publications: 18

Trending Scientists

John Wilkes

John Wilkes

Google (United States)

Feifei Li

Feifei Li

Alibaba Group (China)

Qian Wang (王骞)

Qian Wang (王骞)

Wuhan University

Soo Jin Chua

Soo Jin Chua

National University of Singapore

John W. Palmour

John W. Palmour

Wolfspeed, Inc.

Xiaohong Chen

Xiaohong Chen

Beijing University of Chemical Technology

Matthew Ming Fai Yuen

Matthew Ming Fai Yuen

Hong Kong University of Science and Technology

Réhaume Courtois

Réhaume Courtois

Université Laval

Andreas Karschin

Andreas Karschin

University of Würzburg

Denis Scholz

Denis Scholz

Johannes Gutenberg University of Mainz

Andreas Busch

Andreas Busch

Heriot-Watt University

Ghassan Chebbo

Ghassan Chebbo

École des Ponts ParisTech

H. Craig Heller

H. Craig Heller

Stanford University

Marcel Goldberg

Marcel Goldberg

Inserm : Institut national de la santé et de la recherche médicale

Carol B. Benson

Carol B. Benson

Brigham and Women's Hospital

Margriet S. Westerterp-Plantenga

Margriet S. Westerterp-Plantenga

Maastricht University

Something went wrong. Please try again later.